Juncture Wealth Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Juncture Wealth Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,872	Closed	-$375K	–	74
2016 Q1	$375K	Sell	2,872 -540	-16%	-$67.2K	0.28%	68
2015 Q4	$480K	Sell	3,412 -1,931	-36%	-$268K	0.36%	61
2015 Q3	$710K	Buy	5,343 +1,415	+36%	+$244K	0.58%	46
2015 Q2	$692K	Buy	3,928 +104	+3%	+$18.7K	0.56%	42
2015 Q1	$661K	Buy	+3,824	New	+$656K	0.54%	43

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Juncture Wealth Strategies's JAZZ Position: Q2 2016 in Review

Juncture Wealth Strategies sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2016, closing a stake of 2,872 shares — an estimated $375K sold.

Juncture Wealth Strategies first reported a position in JAZZ in Q1 2015 and held it in 5 quarters. The position peaked at $710K in Q3 2015. 367 funds tracked by Wall St. Rank hold JAZZ as of Q2 2016.

Juncture Wealth Strategies reported no remaining Jazz Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Juncture Wealth Strategies sold 2,872 Jazz Pharmaceuticals shares in Q2 2016, an estimated $375K.
Juncture Wealth Strategies first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 5 quarters.
Juncture Wealth Strategies's Jazz Pharmaceuticals position peaked at $710K in Q3 2015.
367 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2016.

Based on Juncture Wealth Strategies's 13F filing for Q2 2016, filed 14 Jul 2016.